sumitomo-pharma.com
Seen 16 times between May 27th, 2024 and May 27th, 2024.
General Info Open in Search
Created | February 8th, 2021 |
Direct hits
Summary of pages hosted on this domain
Recent scans (13 total) Show all
URL | Age | |||||
---|---|---|---|---|---|---|
www.ca.sumitomo-pharma.com | 11 days | 26 | 6 | 1 | ||
www.us.sumitomo-pharma.com | 20 days | 40 | 10 | 3 | ||
www.ch.sumitomo-pharma.com/index.html | a month | 28 | 10 | 3 | ||
www.us.sumitomo-pharma.com | a month | 43 | 11 | 2 | ||
www.us.sumitomo-pharma.com | 2 months | 40 | 10 | 3 |
Incoming hits
Summary of pages that talked to this domain
Recent scans (3 total) Show all
URL | Age | |||||
---|---|---|---|---|---|---|
www.urovant.com/privacy-policy?utm_source=US-VBGN-2100255&utm_medium=email&ut... | 7 months | 79 | 18 | 3 | ||
enzyvant.com | 7 months | 54 | 12 | 2 | ||
www.sunovion.com | 8 months | 807 | 29 | 3 |
Recently observed hostnames on 'sumitomo-pharma.com'
Searching for newly observed domains and hostnames is possible on our urlscan Pro platform.
propell.us.sumitomo-pharma.com
| 2024-01-15
grace-cdadev.us.sumitomo-pharma.com
| 2023-11-29
orbit-dev2.us.sumitomo-pharma.com
| 2023-11-22
narratory.us.sumitomo-pharma.com
| 2023-11-14
narratory-val.us.sumitomo-pharma.com
| 2023-11-14
orbit-qa.us.sumitomo-pharma.com
| 2023-11-07
grace-spotfire.us.sumitomo-pharma.com
| 2023-10-31
grace-cda.us.sumitomo-pharma.com
| 2023-10-26
grace-spotfiredev.us.sumitomo-pharma.com
| 2023-10-24
admig2.us.sumitomo-pharma.com
| 2023-10-16
admig1.us.sumitomo-pharma.com
| 2023-10-16
counteract2.us.sumitomo-pharma.com
| 2023-09-19
counteract1.us.sumitomo-pharma.com
| 2023-09-19
ae.us.sumitomo-pharma.com
| 2023-09-14
ch.sumitomo-pharma.com
| 2023-09-07
nsxmgr.us.sumitomo-pharma.com
| 2023-09-01
vrni.us.sumitomo-pharma.com
| 2023-09-01
news.us.sumitomo-pharma.com
| 2023-08-21
ca.sumitomo-pharma.com
| 2023-07-07
abacusdev.us.sumitomo-pharma.com
| 2023-05-17
insightvm.us.sumitomo-pharma.com
| 2023-03-28
secret.us.sumitomo-pharma.com
| 2023-03-14
secretdev.us.sumitomo-pharma.com
| 2023-03-07
gracedev-positworkbench2.us.sumitomo-pharma.com
| 2023-02-27
gracedev-positworkbench1.us.sumitomo-pharma.com
| 2023-02-27
gracedev-positpm.us.sumitomo-pharma.com
| 2023-02-27
gracedev-positconnect.us.sumitomo-pharma.com
| 2023-02-27
vision.us.sumitomo-pharma.com
| 2022-11-30
projectanalyticstool.us.sumitomo-pharma.com
| 2022-11-30
projectanalyticstooltest.us.sumitomo-pharma.com
| 2022-11-30
projectanalyticstooldev.us.sumitomo-pharma.com
| 2022-11-30
vpndr.oncology.sumitomo-pharma.com
| 2022-11-28
mft.us.sumitomo-pharma.com
| 2022-09-02
ebs-jar.sumitomo-pharma.com
| 2022-06-09
powerlytics.us.sumitomo-pharma.com
| 2022-04-22
m2lytics.us.sumitomo-pharma.com
| 2022-04-22
itperformance.us.sumitomo-pharma.com
| 2022-04-22
finsightsdev.us.sumitomo-pharma.com
| 2022-04-22
finsights.us.sumitomo-pharma.com
| 2022-04-22
compassdev.us.sumitomo-pharma.com
| 2022-04-22
compass.us.sumitomo-pharma.com
| 2022-04-22
bi360.us.sumitomo-pharma.com
| 2022-04-22
tomo.oncology.sumitomo-pharma.com
| 2022-04-19
tableaudev.us.sumitomo-pharma.com
| 2022-04-05
tableau.us.sumitomo-pharma.com
| 2022-04-05
vpn.us.sumitomo-pharma.com
| 2022-03-30
vdi-internal.us.sumitomo-pharma.com
| 2022-03-30
vdi.us.sumitomo-pharma.com
| 2022-03-30
cva.us.sumitomo-pharma.com
| 2022-03-30
www.oncology.sumitomo-pharma.com
| 2022-03-22
Registration information
Created | February 8th, 2021 |
Updated | June 30th, 2021 |
Registrar | 1API GmbH |
WHOIS for sumitomo-pharma.com
Domain Name: SUMITOMO-PHARMA.COM Registry Domain ID: 2589954529_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.1api.net Registrar URL: http://www.1api.net Updated Date: 2021-06-30T02:08:04Z Creation Date: 2021-02-08T00:10:05Z Registrar Registration Expiration Date: 2025-02-08T00:10:05Z Registrar: 1API GmbH Registrar IANA ID: 1387 Registrar Abuse Contact Email: abuse@1api.net Registrar Abuse Contact Phone: +49.68949396x850 Domain Status: clientTransferProhibited - http://www.icann.org/epp#clientTransferProhibited Registry Registrant ID: Registrant Name: Domain Administrator Registrant Organization: Sumitomo Dainippon Pharma Co., Ltd. Registrant Street: 2-6-8 Dosho-machi, Chuo-ku Registrant City: Osaka-shi Registrant State/Province: Osaka Registrant Postal Code: 541-0045 Registrant Country: JP Registrant Phone: +81.662037011 Registrant Phone Ext: Registrant Fax: Registrant Fax Ext: Registrant Email: dommaster@mark-i.jp Registry Admin ID: Admin Name: Domain Administrator Admin Organization: Sumitomo Pharma Co., Ltd. Admin Street: 2-6-8 Dosho-machi, Chuo-ku Admin City: Osaka-shi Admin State/Province: Osaka Admin Postal Code: 541-0045 Admin Country: JP Admin Phone: +81.662037011 Admin Phone Ext: Admin Fax: Admin Fax Ext: Admin Email: dommaster@mark-i.jp Registry Tech ID: Tech Name: Domain Administrator Tech Organization: Mark-i Inc. Tech Street: 8F Akasaka Tameike Tower, 2-17-7 Akasaka Tech City: Minato-ku Tech State/Province: Tokyo Tech Postal Code: 107-0052 Tech Country: JP Tech Phone: +81.368629956 Tech Phone Ext: Tech Fax: +81.368629931 Tech Fax Ext: Tech Email: dommaster@mark-i.jp Name Server: dns-b.iij.ad.jp Name Server: dns-c.iij.ad.jp DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ >>> Last update of WHOIS database: 2024-05-27T01:36:54Z <<< For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en. ; This data is provided for information purposes, and to assist persons ; obtaining information about or related to domain name registration ; records. We do not guarantee its accuracy. ; By submitting a WHOIS query, you agree that you will use this data ; only for lawful purposes and that, under no circumstances, you will ; use this data to ; 1) allow, enable, or otherwise support the transmission of mass ; unsolicited, commercial advertising or solicitations via E-mail ; (spam); or ; 2) enable high volume, automated, electronic processes that apply ; to this WHOIS server. ; These terms may be changed without prior notice. ; By submitting this query, you agree to abide by this policy.